NASDAQ: LVTXLava Therapeutics Nv Revenue
Lava Therapeutics Nv revenue was $5.80M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LVTX annual revenue was $12.5M, with 65.9% growth year-over-year.
LVTX past revenue growth
How has LVTX's revenue growth performed historically?
Company
-26.2%
Industry
150.55%
Market
20.43%
LVTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LVTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LVTX revenue history
Current Revenue
$5.9M
Current Earnings
-$33.4M
Current Profit Margin
-568.8%
Be the first to know when LVTX announces revenue.
LVTX Revenue History By Year
| LVTX Yearly Revenue | LVTX Revenue | LVTX Change | LVTX Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $12.48M | $4.96M | +65.95% |
| 2023-12-31 | $7.52M | -$13.11M | -63.54% |
| 2022-12-31 | $20.63M | $14.55M | +239.31% |
| 2021-12-31 | $6.08M | $1.51M | +33.05% |
| 2020-12-31 | $4.57M | N/A | N/A |
| 2019-12-31 | $0.00 | N/A | N/A |
Lava Therapeutics Nv Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.